A meta-analysis published in 2019 concluded that there is a relationship between serum resistin levels and IR in patients with T2D and obesity; however, this conclusion was applicable only to subgroups of individuals with above-average resistin levels. This evidence concerns the gene RETN and obesity due to melanocortin 4 receptor deficiency.